Back to all firms
SPRY
ARS PHARMACEUTICALS INC
Tracked Holders (2)
| Manager | % of Portfolio | Activity | Shares | Value | Period |
|---|---|---|---|---|---|
| Daniel Loeb | 0.08% | Buy | 556.2K | $6.5M | Q4 2025 |
| Leon Cooperman | 0.00% | Reduce 61% | 13.1K | $229K | Q2 2025 |